Evidence for homogeneity of thromboxane A2 receptor using structurally different antagonists
- 1 August 1988
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 152 (3) , 311-319
- https://doi.org/10.1016/0014-2999(88)90726-1
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Construction of cat coronary arteries by synthetic thromboxane A2 and its antagonismProstaglandins, 1987
- Antagonism of u46619-induced aggregation of human and canine platelets by four txa2 receptor antagonistsThrombosis Research, 1986
- Further studies on the effects of epimers of thromboxane A2 antagonists on platelets and veinsEuropean Journal of Pharmacology, 1985
- Antagonism of prostaglandin-mediated responses in platelets and vascular smooth muscle by 13-azaprostanoic acid analogsBiochemical Pharmacology, 1985
- Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analoguesBritish Journal of Pharmacology, 1983
- 9,11-Epoxyiminoprosta-5,13-dienoic acid is a thromboxane A2 antagonist in human plateletsNature, 1978
- Thromboxanes: Selective Biosynthesis and Distinct Biological PropertiesScience, 1976
- Release of Additional Factors in Anaphylaxis and its Antagonism by Anti-inflammatory DrugsNature, 1969
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962
- Versuchsanordnung zu Untersuchungen an der BronchiàlmuskulaturNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1940